Search results for "LIPIDS"

showing 10 items of 2228 documents

High Serum Cholesteryl Ester Transfer Rates and Small High-Density Lipoproteins Are Associated With Young Age in Patients With Acute Myocardial Infar…

2007

Objectives Our aim was to characterize cholesteryl ester transfer protein (CETP) activity in the early phase of acute myocardial infarction (MI). Background Cholesteryl ester transfer protein catalyzes the transfer of cholesteryl esters from high-density lipoprotein (HDL) donors to apolipoprotein B-containing lipoprotein acceptors. Methods The CETP concentration, lipid profiles, and the rate of cholesteryl ester transfer (CET) from a tracer dose of radiolabeled HDL toward endogenous lipoproteins were determined within 24 h after symptom onset. Results Among 347 patients with first MI, CETP concentration, triglycerides, and non–HDL-cholesterol increased across tertiles of the CET rate, where…

AdultMaleVery low-density lipoproteinmedicine.medical_specialtyApolipoprotein BHeart disease[SDV]Life Sciences [q-bio]Myocardial Infarction030204 cardiovascular system & hematology03 medical and health scienceschemistry.chemical_compoundSex Factors0302 clinical medicineInternal medicineCholesterylester transfer proteinmedicineHumansProspective StudiesMyocardial infarctionAged030304 developmental biologyAged 80 and over0303 health sciencesbiologyCholesterolbusiness.industryAge FactorsMiddle Agedmedicine.diseaseCholesterol Ester Transfer ProteinsEndocrinologychemistrybiology.proteinCholesteryl esterFemalelipids (amino acids peptides and proteins)Lipoproteins HDLCardiology and Cardiovascular Medicinebusiness[SDV.AEN]Life Sciences [q-bio]/Food and NutritionLipoprotein
researchProduct

Normal intestinal dietary fat and cholesterol absorption, intestinal apolipoprotein B (ApoB) mRNA levels, and ApoB-48 synthesis in a hypobetalipoprot…

1997

Abstract The purpose of this study was to characterize intestinal apolipoprotein B (apoB) metabolism in subjects with familial hypobetalipoproteinemia (FHBL), where segregation analysis supports linkage to the apoB gene but no apoB truncations are present. We investigated cholesterol and fat absorption, intestinal apoB mRNA synthesis and editing, as well as apoB-48 synthesis. Plasma triglycerides (TG) and retinyl palmitate in the chylomicron fractions were analyzed after 12 hours of fasting and then repeatedly for 14 hours after ingestion of a vitamin A—containing high-fat meal. Cholesterol absorption was assessed using a dual stable-isotope method. Mean peak times and concentrations and ar…

AdultMaleVitaminmedicine.medical_specialtyApolipoprotein BEndocrinology Diabetes and Metabolismdigestive systemAbsorptionCholesterol DietaryHypobetalipoproteinemiasEatingchemistry.chemical_compoundEndocrinologyInternal medicineRetinyl palmitatemedicineHumansRNA MessengerIntestinal MucosaHypoalphalipoproteinemiaAgedApolipoproteins BMethioninebiologyCholesterolnutritional and metabolic diseasesNuclease protection assayMiddle Agedmedicine.diseaseDietary FatsLipidsEndocrinologychemistrybiology.proteinFemalelipids (amino acids peptides and proteins)RNA EditingApolipoprotein B-48ChylomicronMetabolism
researchProduct

Oral supplements of vitamin E improve measures of oxidative stress in plasma and reduce oxidative damage to LDL and erythrocytes in β-thalassemia int…

2001

Fifteen beta-thalassemia intermedia patients, not requiring chronic transfusional therapy, were monitored in order to check their antioxidant status, and the lipid oxidation products in plasma, LDL, and erythrocytes before and during a 9-month oral treatment with 600 mg/day vitamin E. The low level of vitamin E, and high level of malondialdehyde in plasma clearly tended to normalize after three months (P < .001), and were quite similar to control after six months. The abnormally low level of vitamin E in LDL and the four times higher than control basal level of conjugated dienes (LDL-CD), were not modified after three months of treatment. Significant changes of LDL-VE (P < .05) and of the b…

AdultMaleVitaminmedicine.medical_specialtyErythrocytesAntioxidantAdolescentmedicine.medical_treatmentAdministration OralHematocritBiochemistryAntioxidantsLipid peroxidationchemistry.chemical_compoundLipid oxidationReference ValuesInternal medicinemedicineHumansVitamin EChildVitamin Amedicine.diagnostic_testVitamin EOsmolar Concentrationbeta-ThalassemiaGeneral MedicineMiddle Agedbeta CaroteneMalondialdehydeLipidsLipoproteins LDLOxidative StressEndocrinologychemistryCase-Control StudiesFemaleHemoglobinFree Radical Research
researchProduct

Prolonged Grief Disorder, Depression, and Posttraumatic Stress Disorder Among Bereaved Kosovar Civilian War Survivors: a Preliminary Investigation

2010

Background: This study aimed at examining diagnostic concordance between Prolonged Grief Disorder (PGD), Major Depressive Disorder (MDD), and Posttraumatic Stress Disorder (PTSD) among bereaved war survivors who had lost relatives due to war-related violence.Method: We investigated the rates of PGD and its association with PTSD and MDD among 60 bereaved people who had lost first-degree relatives due to war-related violence seven years ago and had also experienced other war-related events.Results: The results indicated that 38.3% of the sample fulfilled the criteria for PGD, 55.0% for PTSD, and 38.3% for MDD. Thirty per cent of the participants without PTSD and 21.6% of those without MDD met…

AdultMaleWarfaremedicine.medical_specialtymedia_common.quotation_subjectYugoslaviaPoison controlbehavioral disciplines and activitiesSuicide preventionOccupational safety and healthStress Disorders Post-TraumaticProlonged grief disorderYoung AdultSurveys and Questionnairesmental disordersInjury preventionmedicineHumansSurvivorsPsychiatryDepression (differential diagnoses)Agedmedia_commonDepressionMiddle Agedrespiratory systemmedicine.diseasehumanitiesPsychiatry and Mental healthMajor depressive disorderFemalelipids (amino acids peptides and proteins)GriefGriefPsychologyClinical psychologyInternational Journal of Social Psychiatry
researchProduct

Increased plasma xanthine oxidase activity is related to nuclear factor kappa beta activation and inflammatory markers in familial combined hyperlipi…

2010

Abstract Background and aims Xanthine oxidase (XO) has been described as one of the major enzymes producing free radicals in blood. Oxidative stress and inflammatory processes have been implicated in the pathogenesis of endothelial dysfunction and the progression of atherosclerosis but until now, there is little data about the influence of vascular prooxidant systems and inflammation in familial combined hyperlipidemia (FCH). Our goal was to evaluate whether XO activity was altered in FCH and if it was related to the inflammatory process represented by NFkB, IL-6 and hsCRP, and assessing the correlation between XO activity and insulin resistance (IR). Method and results 40 Non-related subje…

AdultMaleXanthine Oxidasemedicine.medical_specialtyFree RadicalsEndocrinology Diabetes and Metabolismmedicine.medical_treatmentHyperlipidemia Familial CombinedMedicine (miscellaneous)Inflammationmedicine.disease_causechemistry.chemical_compoundInsulin resistanceMalondialdehydeInternal medicineHyperlipidemiamedicineHumansXanthine oxidaseInflammationNutrition and Dieteticsmedicine.diagnostic_testInterleukin-6business.industryInsulinNF-kappa BMiddle AgedAtherosclerosismedicine.diseaseLipidsOxidative StressC-Reactive ProteinLogistic ModelsEndocrinologychemistryMultivariate AnalysisUric acidFemaleEndothelium VascularLipid PeroxidationInsulin Resistancemedicine.symptomCardiology and Cardiovascular MedicineLipid profilebusinessBiomarkersOxidative stressNutrition, Metabolism and Cardiovascular Diseases
researchProduct

Phytosterol plasma concentrations and coronary heart disease in the prospective Spanish EPIC cohort

2010

Phytosterol intake with natural foods, a measure of healthy dietary choices, increases plasma levels, but increased plasma phytosterols are believed to be a coronary heart disease (CHD) risk factor. To address this paradox, we evaluated baseline risk factors, phytosterol intake, and plasma noncholesterol sterol levels in participants of a case control study nested within the European Prospective Investigation into Cancer and Nutrition (EPIC) Spanish cohort who developed CHD (n = 299) and matched controls (n = 584) who remained free of CHD after a 10 year follow-up. Sitosterol-to-cholesterol ratios increased across tertiles of phytosterol intake (P = 0.026). HDL-cholesterol level increased, …

AdultMalecampesterolmedicine.medical_specialtyCampesterolPopulationCoronary DiseaseLathosterolQD415-436lathosterolBiochemistryplant sterolsCohort Studieschemistry.chemical_compoundEndocrinologyRisk FactorsInternal medicineHumansMedicineProspective StudiesRisk factoreducationProspective cohort studyAgededucation.field_of_studyCholesterolbusiness.industrycholesterolPhytosterolsCell BiologyEuropean Prospective Investigation into Cancer and NutritionMiddle AgedDietEuropean Prospective Investigation into Cancer and NutritionEndocrinologysitosterolchemistrySpainCase-Control StudiesNested case-control studyFemalelipids (amino acids peptides and proteins)Patient-Oriented and Epidemiological ResearchbusinessJournal of Lipid Research
researchProduct

Long term hemodialysis aggravates lipolytic activity reduction and very low density, low density lipoproteins composition in chronic renal failure pa…

2009

Abstract Background Dyslipidemia, particularly hypertriglyceridemia is common in uremia, and represents an independent risk factor for atherosclerosis. Methods To investigate the effects of hemodialysis (HD) duration on very low density lipoprotein (VLDL) and low density lipoprotein (LDL) compositions and lipopolytic activities, 20 patients on 5 to 7 years hemodialysis were followed-up during 9 years. Blood samples were drawn at T0 (beginning of the study), T1 (3 years after initiating study), T2 (6 years after initiating study) and T3 (9 years after initiating study). T0 was taken as reference. Results Triacylglycerols (TG) values were correlated with HD duration (r = 0.70, P Conclusion De…

AdultMalelcsh:Diseases of the circulatory (Cardiovascular) systemVery low-density lipoproteinmedicine.medical_specialtyTime Factorsmedicine.medical_treatmentLipolysisBlood lipidsLipoproteins VLDLRisk Assessmentchemistry.chemical_compoundRenal DialysisRisk FactorsInternal medicinemedicineHumansInsulinLongitudinal StudiesTriglyceridesDyslipidemiasLipoprotein lipaseApolipoprotein C-IIICholesterolbusiness.industryHypertriglyceridemianutritional and metabolic diseasesLipaseMiddle Agedmedicine.diseaseAtherosclerosisLipoproteins LDLLipoprotein LipaseEndocrinologyCholesterolchemistrylcsh:RC666-701Low-density lipoproteinLinear ModelsKidney Failure Chroniclipids (amino acids peptides and proteins)Apolipoprotein C-IIFemaleHepatic lipaseHemodialysisCardiology and Cardiovascular MedicinebusinessBiomarkersResearch ArticleBMC cardiovascular disorders
researchProduct

Gender differences on oxidative stress markers and complement component C3 plasma values after an oral unsaturated fat load test

2020

Abstract Objective Post-prandial lipaemia (PL), oxidative stress (OS), and complement component C3 (C3) values are related to the atherosclerosis process. The post-prandial response of C3 after an oral fat load test (OFLT) using unsaturated fat is poorly addressed. The aim of this study was to analyze and compare the post-prandial response of OS markers and C3 values in men and women after an OFLT using unsaturated fat. Methods The study included a total of 22 healthy subjects with normal lipids and normal blood glucose (11 men and 11 pre-menopausal women). An oral unsaturated fat load test (OFLT: 50 g fat per m2 body surface) was performed using a commercial liquid preparation of long chai…

AdultMalemedicine.medical_specialty030209 endocrinology & metabolismmedicine.disease_cause03 medical and health scienceschemistry.chemical_compoundSex Factors0302 clinical medicineInternal medicinemedicineHumansPharmacology (medical)TriglyceridesFasting stateGeneral Environmental Science030219 obstetrics & reproductive medicineGlutathione Disulfidebusiness.industryUnsaturated fatHealthy subjectsGeneral EngineeringComplement C3FastingGlutathioneMiddle AgedPostprandial PeriodGlutathioneLipidsFats UnsaturatedOxidized GlutathioneOxidative StressEndocrinologychemistryGeneral Earth and Planetary SciencesFemaleCardiology and Cardiovascular MedicineNormal blood glucosebusinessLong chainBiomarkersOxidative stressClínica e Investigación en Arteriosclerosis (English Edition)
researchProduct

Treatment of Fabry's Disease With Migalastat: Outcome From a Prospective Observational Multicenter Study (FAMOUS).

2019

Fabry's disease (FD) is an X-linked lysosomal storage disorder caused by the deficient activity of the lysosomal enzyme alpha-galactosidase A (alpha-Gal A) leading to intracellular accumulation of globotriaosylceramide (Gb3). Patients with amenable mutations can be treated with migalastat, a recently approved oral pharmacologic chaperone to increase endogenous alpha-Gal A activity. We assessed safety along with cardiovascular, renal, and patient-reported outcomes and disease biomarkers in a prospective observational multicenter study after 12 months of migalastat treatment under real-world conditions. Fifty-nine (28 females) patients (34 (57.6%) pretreated with enzyme replacement therapy) w…

AdultMalemedicine.medical_specialty1-DeoxynojirimycinTime FactorsGlobotriaosylceramideRenal function030226 pharmacology & pharmacyGastroenterologyVentricular Function Left03 medical and health scienceschemistry.chemical_compound0302 clinical medicineInternal medicineMigalastatGermanymedicineClinical endpointHumansPharmacology (medical)Genetic Predisposition to DiseaseProspective StudiesPharmacologySphingolipidsVentricular Remodelingbusiness.industryEnzyme replacement therapyMiddle Agedmedicine.diseaseFabry's diseaseFabry diseaseBlood pressureTreatment Outcomechemistry030220 oncology & carcinogenesisalpha-GalactosidaseMutationFabry DiseaseFemaleGlycolipidsbusinessBiomarkersGlomerular Filtration RateClinical pharmacology and therapeutics
researchProduct

Characterization of hypoechoic focal hepatic lesions in patients with fatty liver: diagnostic performance and confidence of contrast-enhanced ultraso…

2007

The objective of this study was to assess the diagnostic performance of contrast-enhanced ultrasound (CEUS) to characterize hypoechoic focal hepatic lesions (HFHL) in fatty liver (FL). A study group of 105 patients with FL and 105 HFHLs (52 malignant and 53 benign) underwent CEUS after SonoVue administration. Two blinded readers independently reviewed baseline ultrasound (US) and CEUS scans and classified each lesion as malignant or benign on a five-point scale of confidence, and recorded whether further imaging work-up was needed. Sensitivity, specificity, areas under the receiver operating characteristic (ROC) curve (A (z)), and interobserver agreement were calculated. We observed that th…

AdultMalemedicine.medical_specialtyAdenomaSulfur HexafluorideContrast MediaSensitivity and SpecificityAdenoma Liver CellCholangiocarcinomaFocal Hepatic LesionsFatty LiverContrast-enhanced UltrasoundHumansMedicinecontrast-enhanced ultrasoundfatty liverfocal hepatic lesionsRadiology Nuclear Medicine and imagingProspective StudiesProspective cohort studyPhospholipidsAgedUltrasonographyNeuroradiologyAged 80 and overObserver VariationHyperplasiamedicine.diagnostic_testReceiver operating characteristicbusiness.industryLiver NeoplasmsUltrasoundFatty liverCONTRAST-ENHANCED ULTRASOUNDFATTY LIVERFOCAL HEPATIC LESIONInterventional radiologyGeneral MedicineMiddle Agedmedicine.diseaseFatty LiverLiverROC CurveArea Under CurveFemaleRadiologyHemangiomabusinessContrast-enhanced ultrasoundEuropean Radiology
researchProduct